BANDER; Neil H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BANDER; Neil H..The latest application filed is for "methods and reagents for tumor targeting with greater efficacy and less toxicity".

Company Profile

4.19.23

BANDER; Neil H. - Chappaqua NY
Bander; Neil H. - New York NY
BANDER; Neil H - Chappaqua NY
Bander, Neil H. - Chappagua NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Reagents For Tumor Targeting With Greater Efficacy And Less Toxicity App 20210196844 - BANDER; Neil H.	2021-07-01
Methods And Reagents For Tumor Targeting With Greater Efficacy And Less Toxicity App 20210154338 - BANDER; Neil H.	2021-05-27
Methods and kits for diagnosis of cancer and prediction of therapeutic value Grant 10,517,969 - Bander , et al. Dec	2019-12-31
Treatment of Proliferative Disorders Using Antibodies to PSMA App 20190070322 - Bander; Neil H.	2019-03-07
Androgen Suppression, Prostate-Specific Membrane Antigen and the Concept of Conditionally Enhanced Vulnerability App 20180208676 - Bander; Neil H.	2018-07-26
Elevated PSMA Identifies Lethal Prostate Cancers App 20180088120 - Bander; Neil H.	2018-03-29
Methods Of Treating Prostate Cancer With Anti-prostate Specific Membrane Antigen Antibodies App 20170037142 - Bander; Neil H.	2017-02-09
Treatment And Diagnosis Of Cancer App 20150316553 - Bander; Neil H.	2015-11-05
Treatment of Proliferative Disorders Using Antibodies to PSMA App 20150056135 - Bander; Neil H.	2015-02-26
Treatment and diagnosis of cancer Grant 8,951,737 - Bander February 10, 2	2015-02-10
Androgen Suppression, Prostate-Specific Membrane Antigen and the Concept of Conditionally Enhanced Vulnerability App 20140099257 - BANDER; Neil H.	2014-04-10
PSMA as a BioMarker for Androgen Activity in Prostate Cancer App 20130315830 - BANDER; Neil H.	2013-11-28
Elevated PSMA Identifies Lethal Prostate Cancers App 20130225541 - BANDER; Neil H	2013-08-29
Treatment of Proliferative Disorders Using Antibodies to PSMA App 20100291113 - Bander; Neil H.	2010-11-18
Treatment and diagnosis of prostate cancer Grant 7,666,425 - Bander February 23, 2	2010-02-23
Methods Of Treating Prostate Cancer With Anti-prostate Specific Membrane Antigen Antibodies App 20090280120 - Bander; Neil H.	2009-11-12
Treatment and Diagnosis of Cancer App 20090238755 - Bander; Neil H.	2009-09-24
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies Grant 7,514,078 - Bander , et al. April 7, 2	2009-04-07
Treatment and diagnosis of cancer Grant 7,163,680 - Bander January 16, 2	2007-01-16
Treatment and diagnosis of cancer App 20060275212 - Bander; Neil H.	2006-12-07
Treatment and diagnosis of prostate cancer Grant 7,112,412 - Bander September 26, 2	2006-09-26
Treatment and diagnosis of cancer Grant 6,770,450 - Bander August 3, 2	2004-08-03
Treatment and diagnosis of prostate cancer Grant 6,767,711 - Bander July 27, 2	2004-07-27
Methods and compositions for treating or preventing insulin-related disorders using binding agents specific for prostate specific membrane antigen App 20040136998 - Bander, Neil H.	2004-07-15
Modified antibodies to prostate-specific membrane antigen and uses thereof App 20040120958 - Bander, Neil H. ; et al.	2004-06-24
Treatment and diagnosis of prostate cancer App 20040105865 - Bander, Neil H.	2004-06-03
Method for isolation of cells from a solution App 20040087017 - Bander, Neil H. ; et al.	2004-05-06
Method for isolation of cells from a solution Grant 6,653,129 - Bander , et al. November 25, 2	2003-11-25
Treatment and diagnosis of cancer Grant 6,649,163 - Bander November 18, 2	2003-11-18
Treatment and diagnosis of cancer App 20030031673 - Bander, Neil H.	2003-02-13
Treatment and diagnosis of prostate cancer App 20030003101 - Bander, Neil H.	2003-01-02
Treatment and diagnosis of prostate cancer App 20020015704 - Bander, Neil H.	2002-02-07
Drainage catheter Grant 6,299,598 - Bander October 9, 2	2001-10-09
Treatment and diagnosis of cancer Grant 6,136,311 - Bander October 24, 2	2000-10-24
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains Grant 6,107,090 - Bander August 22, 2	2000-08-22
Enhanced reverse transcriptase polymerase chain assay to detect MN in patients with renal cell carcinoma Grant 6,087,098 - McKiernan , et al. July 11, 2	2000-07-11
Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood Grant 5,773,292 - Bander June 30, 1	1998-06-30
Method for characterizing types of renal carcinoma and prognosis Grant 4,935,344 - Bander , et al. June 19, 1	1990-06-19
Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma Grant 4,713,352 - Bander , et al. December 15, 1	1987-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.